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1  | INTRODUC TION
It is beyond dispute that dental implants have long-term (≥10 year) 
survival rates over 90% (Howe, Keys, & Richards, 2019; Pjetursson, 
Thoma, Jung, Zwahlen, & Zembic, 2012). However, dental implants 
are subject to biological complications known as peri-implant dis-
eases (Renvert, Persson, Pirih, & Camargo, 2018). While tissue 
inflammation is a hallmark of both peri-implant mucositis and peri-
implantitis, only the latter form presents with progressive loss of 
supporting bone (Lindhe et al., 2008). The reported prevalence of 
peri-implant mucositis ranged from 19% to 65% (weighted mean of 
42.9%), while for peri-implantitis prevalence ranged from 1% to 47% 
(weighted mean of 22%) (Derks & Tomasi, 2015). Peri-implantitis 
prevalence was positively correlated with function time and nega-
tively correlated with threshold for bone loss (Derks & Tomasi, 2015).
Several conditions have been identified as putative risk factors 
or risk indicators for peri-implantitis including diabetes, smoking, 
history of periodontitis, poor plaque control, lack of regular main-
tenance therapy, inadequate width of keratinized mucosa (KM), 
implant malpositioning, among others (Hammerle & Tarnow, 2018; 
Schwarz, Derks, Monje, & Wang, 2018). One factor that is routinely 
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Abstract
Aim: To assess the impact of keratinized mucosa (KM) width around dental implants 
on surgical therapeutic outcomes when treating peri-implantitis.
Material and Methods: Surgically treated peri-implantitis implants were divided 
into two groups (KM width < 2 mm and ≥2 mm). Retrospective data were obtained 
after implant placement (T0) and the day of peri-implantitis surgical treatment (T1). 
Patients were later recruited (≥1 year after T1) for clinical and radiographic exami-
nation (T2). Outcomes were analysed using generalized estimating equation (GEE) 
models.
Results: A total of 40 patients (68 implants) (average follow-up: 52.4 ± 30.5 months) 
were included in this study. From T0 to T1, no differences were found between KM 
groups in terms of peri-implant probing depths (PPD) and bleeding on probing (BOP). 
However, sites with <2 mm KM exhibited significantly higher suppuration (SUP) and 
lower marginal bone level (MBL) (p > .01). Between T1 and T2, no major differences 
were noted on PPD reduction, BOP and MBL changes between the two groups. GEE 
modelling demonstrated that MBL severity prior to surgical therapy was a better 
predictor for implant survival than KM width.
Conclusion: Surgical outcome in treating peri-implantitis was influenced by the se-
verity of bone loss present at the time of treatment and not by the presence of KM 
at the time of treatment.
K E Y W O R D S
dental implants, disease management, keratinized mucosa, peri-implantitis
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investigated is the significance of KM on peri-implant health (Chung, 
Oh, Shotwell, Misch, & Wang, 2006; Kim et al., 2009; Lin, Chan, & 
Wang, 2013). A lack of KM has been associated with higher levels 
of prostaglandin E2 (Zigdon & Machtei, 2008), which might explain 
the positive effect of KM on the development and resolution of ex-
perimental mucositis in humans (Schwarz et al., 2018b). Hence, its 
presence seems essential for maintenance of long-term peri-implant 
health (Listgarten, Lang, Schroeder, & Schroeder, 1991). While few 
studies reported that presence of KM was associated with peri-im-
plantitis (Roos-Jansaker, Lindahl, Renvert, & Renvert, 2006), there 
is building evidence to support a positive correlation between 
the presence of peri-implantitis and sites with <2 mm KM (Bouri, 
Bissada, Al-Zahrani, Faddoul, & Nouneh, 2008), where others sug-
gest that the evidence to support this finding is limited (Bengazi, 
Wennstrom, & Lekholm, 1996; Crespi, Cappare, & Gherlone, 2010; 
Frisch, Ziebolz, Vach, & Ratka-Kruger, 2015; Wennstrom, Bengazi, & 
Lekholm, 1994; Wennstrom & Derks, 2012). Recent data support the 
understanding that an adequate width of KM is crucial in patients 
exhibiting poor compliance with peri-implant maintenance (Monje & 
Blasi, 2019), but plays a lesser role in fully compliant patients (Lim, 
Wiedemeier, Hammerle, & Thoma, 2019).
Although disagreement exists in the literature, the majority of 
studies agreed that the absence or lack (<2 mm) of KM was more 
likely to be associated with increased plaque accumulation, tis-
sue inflammation, recession, attachment loss and reduced quality 
of self-performed oral hygiene measures (Gobbato, Avila-Ortiz, 
Sohrabi, Wang, & Karimbux, 2013; Lin et al., 2013; Ueno et al., 2016). 
These findings suggest that the presence of KM should be important 
not only for maintaining peri-implant health, but also during surgical 
therapy of peri-implantitis and long-term maintenance.
The influence of KM on the prevalence of peri-implant diseases 
can be argued according to population studies. However, it remains 
unknown whether the presence of KM plays a significant role in the 
treatment of peri-implant diseases. Hence, the aim of this study was 
to explore the impact of KM on the outcomes of peri-implantitis 
treatment before and after surgical therapy.
2  | MATERIAL AND METHODS
This retrospective study was conducted in accordance with 
the Declaration of Helsinki on human studies, approved by the 
University of Michigan School of Dentistry Institutional Review 
Board (IRB) for Human Studies (HUM00148346), and registered 
in Clinicaltrials.gov (ID: NCT03772652). Physical and digital re-
cords collected from patients treated for peri-implantitis from 2008 
to 2018 at the University of Michigan School of Dentistry were 
screened and evaluated by three examiners (IS, AR, RS). Patients 
with functional treated implants were invited to participate in the 
study and recruited after signing a written informed consent form 
for data collection from January 2019 to June 2019. Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) 
guidelines were followed during the preparation of the manuscript.
2.1 | Eligibility criteria
To be included in this study, patients had to fall under the follow-
ing predetermined eligibility criteria: (a) presence of at least one 
dental implant previously diagnosed with peri-implantitis using the 
American Academy of Periodontology (AAP)/European Federation 
of Periodontology (EPF) 2017 World Workshop on the Classification 
of Periodontal and Peri-implant Diseases and Conditions guidelines 
(Berglundh, Armitage, et al., 2018), (b) complete clinical and radio-
graphic pre-surgical documentation, (c) documented follow-up of 
≥1 year following surgical therapy for peri-implantitis with either 
resective or regeneration therapy (Table S1), (d) ≥1 maintenance ses-
sion per year within the University of Michigan School of Dentistry 
after surgical treatment of peri-implantitis and (e) presence of oppos-
ing occlusion. Patients were excluded if: (a) clinical and radiographic 
records were incomplete or not available, (b) follow-up <1 year after 
surgical therapy and (c) peri-implantitis treatment and maintenance 
therapy was rendered outside the University of Michigan School of 
Dentistry.
2.2 | Data collection and classification
As part of the data collection process, all relevant patient infor-
mation including gender, age at the time of the treatment of peri-
implantitis, self-reported cigarette consumption (≥1 cigarette/day), 
diabetes and history of periodontal disease as defined by the World 
Workshop (Tonetti, Greenwell, & Kornman, 2018) were collected. 
Patients were assessed at T0, T1 and T2, where T0 represented 
implant placement or prosthetic placement, T1 represented peri-
implantitis treatment and T2 represented follow-up after treatment 
where patients were recalled. Patients files were examined at T0 to 
collect clinical parameters such as KM width and radiographs. KM 
width was defined as the distance measured between the free mu-
cosal margin to the mucogingival junction at the mid-buccal site, 
Clinical Relevance
Scientific rationale for the study: The significance of kerati-
nized mucosa (KM) on peri-implant diseases has been ex-
tensively investigated. Nevertheless, the impact of KM on 
therapeutic outcomes remains unknown.
Principal findings: Keratinized mucosa might play a more 
crucial role in the progression of peri-implant diseases 
rather than in the response to surgical therapy.
Practical implication: While progression of peri-implantitis 
is associated with a lack of KM, therapeutic outcomes are 
mainly influenced by severity of bone loss.
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utilizing the North Carolina probe (Hu-Friedy, Chicago, IL, USA). The 
selected cases were then separated into two groups based on the 
amount of KM: KM < 2 mm and KM ≥ 2 mm. The following informa-
tion was collected from patient files at T1: KM width, radiographs, 
peri-implant probing depths (PPD) (recorded in millimetres using a 
North Carolina probe), bleeding on probing (BOP) and suppuration 
(SUP) (dichotomous (1/0) scale using a North Carolina probe) and 
peri-implant marginal bone level (MBL). Peri-implant MBL was con-
sidered as the distance between the most coronal part of the implant 
expected to be in bone-to-implant contact (for tissue-level implants: 
the interface between the polished collar and rough surface, and for 
bone level implants with rough surface: the platform level) to the 
most coronal point of the implant body in contact with bone. For 
each radiograph, the MBL was measured by two authors (CGP, RS) at 
the mesial and distal aspects of the affected implants using commer-
cially available software (ImageJ, U. S. National Institutes of Health, 
Bethesda, MD, USA). MBL was also categorized in percentage 
(<25%; 25%–50%; or >50%) of the implant at the interproximal sites 
that had no bone-implant-contact considering the length of the im-
plant. Implant design was taken in consideration for this analysis, and 
therefore, implants with a polished collar were analysed as complete 
length being from the smooth-rough interface in apical direction. 
Repeated measurements of 15 implants were conducted to quantify 
mean intra- and inter-agreement measurement errors: 0.36 ± 0.4 
and 0.57 ± 0.6, respectively. Changes in the width of KM from T0 
to T1 were observed. Implants that were initially in the KM ≥ 2 mm 
group at T0 might have switched to the KM < 2 mm group by this 
point (T1) or vice versa; depending on the rendered KM lose or gain.
If the treated implant was found to be in function based on the 
information on file in the patient chart during the last appointment 
in our clinic, the patient was contacted and invited to participate in 
this study (T2 appointment). In case of implant failure, the date of 
the implant removal was recorded, and the implant was included 
in the analysis, but the patient was not contacted (no T2 appoint-
ment). During patient recalls, all the aforementioned clinical and ra-
diographic parameters were remeasured. In addition, plaque index 
(Silness & Loe, 1964) was recorded by one expert examiner (CGP). 
Additional information regarding type of surgical intervention (re-
sective surgery or guided bone regeneration), previous non-surgical 
therapy, number of maintenance visits, systemic antibiotic prescrip-
tion, and the characteristics of the implants and prosthesis were also 
gathered.
2.3 | Treatment success
An extensive search of all available peri-implantitis treatment suc-
cess criteria was performed. The most employed success criteria 
after treatment of peri-implantitis were defined as PPD < 5 mm, 
absence of BOP/SUP, and no progressive radiographic marginal 
bone loss (Criteria 1) (Berglundh, Wennstrom, & Lindhe, 2018; Cha, 
Lee, & Kim, 2019; Charalampakis, Rabe, Leonhardt, & Dahlen, 2011; 
Heitz-Mayfield & Mombelli, 2014; Heitz-Mayfield et al., 2018; Isler, 
Soysal, Ceyhanli, Bakirarar, & Unsal, 2018; de Tapia et al., 2019). 
Criteria 1 were used to define success after both resective and 
regenerative treatment at T2. An additional composite modified 
criteria (Criteria 2) were used at T2 to define success around im-
plant sites treated with regenerative therapy (PPD < 5 mm, modi-
fied sulcus bleeding index [SBI] in <25% of sites, and defect bone 
fill of >25% or >1 mm) (Mombelli, Oosten, Schurch, & Land, 1987; 
Renvert, Roos-Jansaker, & Persson, 2018; Roos-Jansaker, Persson, 
Lindahl, & Renvert, 2014).
2.4 | Statistical analysis
Binary logistic regression was conducted to evaluate post-surgical 
outcomes based on pre-surgical KM width using generalized esti-
mating equations (GEE) adjusted to account for differences in fol-
low-up period, number of maintenance visits and type of procedure 
performed between T0, T1 and T2. The changes in BOP and SUP 
rates from T1 to T2 among the two KM groups were analysed with a 
model labelled as “interaction group KM-time.” For changes in mean 
PPD (at six sites) and mean MBL (mesial and distal), general linear 
models were used under the GEE approach. The GEE methodology 
was used to control the intra-subject correlation due to the multi-
plicity of implants. The level of significance utilized in the analyses 
was 5% (α = 0.05). A logistic regression model reached a power of 
82.6% to detect an odds ratio (OR) = 4 and deemed significant in a 
hypothetical sample of 68 totally independent implants assuming a 
confidence level of 95%. Due to the multi-level design of the data 
(several implants per patient), the power was corrected assuming 
a moderate intra-subject correlation (ρ = 0.5) resulting in a power 
of 72%.
3  | RESULTS
One hundred forty-three patients received treatment of peri-im-
plantitis at University of Michigan school of Dentistry; however, 
103 were excluded for the following reason: 23 patients had the 
implants placed outside the school and information at T0 were not 
available, 2 patients passed away, 6 patients moved and were not 
able to come to the appointment at T2, 14 patients could not be con-
tacted, 33 patients had incomplete information at T0 or T1, 14 did 
not want to be part of the research study, 5 patients were treated 
before implants were restored, and for 6 patients the implants were 
extracted < 1 year after surgical treatment of peri-implantitis. A 
total of 40 patients including 22 women (55%) and 18 men (45%) 
with a mean age of 64.5 ± 9.0 years (range: 43–87 years) were re-
cruited for this study. At T0, a total of 68 implants (KM < 2 mm = 26; 
KM ≥ 2 = 42) were included in the study (Table S2). Thirteen im-
plants with KM ≥ 2 mm at T0 (implant placement) lost KM width 
due to the peri-implant disease process and were then moved to 
the KM < 2 mm group at T1 (peri-implantitis surgical treatment). 
Hence, 39 implants with < 2 mm KM and 29 with ≥2 mm KM were 
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diagnosed with and treated for peri-implantitis (T1) receiving ei-
ther resective or regenerative therapy with a mean follow-up of 
52.4 ± 30.5 months (Figure S1). In total, 10% percent of the patients 
were smokers, 10% presented with hyperglycaemia, and 62.5% had 
a history of periodontitis at the time of the surgical phase for the 
management of peri-implantitis. Demographic data and relevant 
pre- surgical treatment of peri-implantitis (T1) information were in-
cluded in Table 1.
3.1 | Changes from implant placement to the day of 
surgery (T0–T1)
The duration of time between implant placement and surgical 
treatment of peri-implantitis was longer for dental implants with 
<2 mm KM relative to those with ≥2 mm KM (T0–T1) (p = .087). 
Furthermore, patients with peri-implant sites presenting with 
<2 mm KM exhibited a similar frequency of periodontal mainte-
nance sessions (p = .607). The association between KM, clinical, 
and radiographic parameters at T1 are shown in Figure 1 and 
Table 2. At T1 no statistically significant difference was found 
between the two groups of KM width in terms of PPD and BOP 
(p > .05). However, sites with <2 mm KM had a fivefold increase 
(OR = 5.02) in SUP compared to sites with ≥2 mm KM (p = .025). 
Simple linear regression using GEE to control differences in time 
and maintenance showed that sites with < 2mm KM exhibited sig-
nificantly lower MBL at T1 than sites with ≥2 mm KM (p < .01). Sites 
with <2 mm KM had a fivefold higher risk for having MBL > 25% 
(p = .012) and 11-fold higher risk for MBL > 50% (p = .011) com-
pared to sites with ≥2 mm KM.
3.2 | Changes after treatment of peri-implantitis 
(T1–T2)
Clinical and radiographical parameters prior surgical treatment for 
peri-implantitis are shown in Table 3. Twelve out of 68 implants were 
removed after surgical treatment giving an overall survival rate of 
82.4%. When considering KM width, 11 out of 39 implants (28.2%) 
were removed in the <2 mm KM group, while only 1 out of 29 im-
plants (3.4%) were lost in the ≥2 mm KM group. Treated implant 
sites with <2 mm KM displayed a shorter follow-up after treatment 
(p = .075) when compared to ≥2 mm KM sites.
After adjusting the model for the number of maintenance visits 
and MBL at T1, it was found that sites with <2 mm KM had sixfold 
increased risk for failure relative to sites with ≥2 mm KM (p = .13). It 
should be noted that multivariate analysis yielded that the position 
of the MBL could predict implant survival rate prior to treatment 
being rendered (p = .05) (Table 4). Seven of the 11 implant failures in 
the <2 mm KM group presented with MBL > 50% at T1. The risk of 
future implant failure increased by 65% for each additional millime-
tre of MBL measured at T1.
In terms of PPD reduction, no statistically significant difference 
was found after adjusting for differences in follow-up time and num-
ber of maintenance visits between the two KM width groups regard-
less of regenerative (p = .1) or resective therapy (p = .5) (Figure 2a). At 
F I G U R E  1   Implant marginal bone level 
(MBL) distribution between T0 and T1 
according to time (years) and keratinized 
mucosa (KM) width
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TA B L E  1   Overall demographic data prior to the surgical treatment for peri-implantitis (T1)
KM
OR 95% CI p-value≥2 mm <2 mm
n (Implants) T1 29 39
Mean KM T1 (mm) 3.03 ± 1.59 0.38 ± 0.49
Time between T1 
andT2 (months)
60.9 ± 31.3 46.0 ± 28.5 0.98 0.97–1.00 .075
Implant site (T1) .224
Incisor 4 (13.8) 8 (20.5) 1
Canine 1 (3.4) 4 (10.3) 2.00 0.35–11.3 .433
Premolar 13 (44.8) 7 (17.9) 0.27 0.06–1.21 .087
Molar 11 (37.9) 20 (51.3) 0.91 0.21–3.97 .899
Area (T1)
Anterior 5 (17.2) 12 (30.8) 1
Posterior 24 (82.8) 27 (69.2) 0.47 0.11–2.00 .469
Maxillary 15 (51.7) 11 (28.2) 1




1/per year 16 (55.2) 9 (23.1) 1
2/per year 8 (27.6) 18 (46.2) 4.00 1.13–14.2 .032*
≥3/per year 5 (17.2) 12 (30.8) 4.27 1.12–16.3 .034*
Bone Graft (T1)
No 14 (51.9) 31 (79.5) 1
Yes 13 (48.1) 8 (20.5) 0.28 0.09–0.86 .027*
Implant design (T1)
Bone level 26 (89.7) 34 (87.2) 1




Internal 19 (65.5) 21 (53.8) 1
External 9 (31.0) 16 (41.0) 1.61 0.46–5.66 .459
Ball Attachment 1 (3.4) 2 (5.1) 1.81 0.79–4.14 .160
Type of prosthesis 
retention (T1)
.001**
Cement 22 (75.9) 25 (64.1) 1
Screw 6 (20.7) 10 (25.6) 1.47 0.47–4.60 .511
Locator/bar 
attachment
1 (3.4) 4 (10.3) 3.52 1.58–7.83 .002**
Splinted (T1)
No 17 (58.6) 13 (33.3) 1
Yes 12 (41.4) 26 (66.7) 2.83 0.87–9.25 .084
Opposing dentition (T1)
Natural 23 (79.3) 29 (74.4) 1
Others 6 (20.7) 10 (25.6) 1.32 0.32–5.50 .701
Previous non-surgical therapy
No 16 (55.2) 16 (41.0) 1
Yes 13 (44.8) 23 (59.0) 1.77 0.59–5.34 .312
(Continues)
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T1, BOP was present at 100% of peri-implant sites in both groups. At 
T2, BOP was measured at 90% of sites in both groups after regenera-
tive therapy, and at 88.9% (KM < 2 mm) and 87.5% (KM ≥ 2 mm) after 
resective therapy (p > .05). SUP was reduced from 80% to 40% at 
sites with <2 mm KM and from 60% to 45% at sites with ≥2 mm when 
treated with regenerative therapy (p > .05). SUP decreased from 
72.2% to 5.6% in the <2 mm KM group and from 57% to 42.9% at 
sites with ≥2 mm KM after resective therapy (p < .01). MBL changes 
in both KM groups showed no differences (p > .05) between resective 
or regenerative treatment approaches (Figure 2b).
During T2, PI scores were 1.37 ± 0.88 at the sites with <2 mm 
KM and 1.36 ± 0.81 at sites with ≥2 mm KM (p > .05). GI score was 
significantly (p = .013) lower at sites with <2 mm KM (1.56 ± 0.64) 
when compared to the ≥2 mm KM group (1.92 ± 0.57). Maintenance 
frequency exhibited a significant effect on GI score (beta = −0.33, 
p = .001); for each additional annual maintenance visit, the GI score 
was reduced by 0.20 points.
3.3 | Success rate after treatment of peri-implantitis
Table 5 shows the number and percentage of implants that re-
sponded to surgical therapy. Based on the selected criteria, the over-
all treatment success was accomplished in 10.3% and 7.7% of cases 
among sites with ≥2 mm and <2 mm KM, respectively. Success rates 
were 9.1% and 23.5% when regeneration therapy was performed at 
KM
OR 95% CI p-value≥2 mm <2 mm
Surgical approach (T1)
Regenerative 20 (69.0) 19 (48.7) 1
Resective 9 (31.0) 20 (51.3) 2.34 0.74–7.41 .148
Type of bone graft 
T1(n = 39)
n = 20 n = 19
Allograft 17 (85.0) 18 (94.7) 1
Xenograft 3 (15.0) 1 (5.3) 0.32 0.05–1.88 .205
Antibiotics (T1) .883
No 9 (31.0) 10 (25.6) 1
Amoxicillin 13 (44.8) 19 (48.7) 1.32 0.37–4.73 .675
Azithromycin 2 (6.9) 5 (12.8) 2.25 0.12–43.8 .593
Clindamycin 5 (17.2) 5 (12.8) 0.90 0.21–3.78 .886
Abbreviation: KM, keratinized mucosa.
*p < .05; **p < .01. 
TA B L E  1   (Continued)
≥2 mm <2 mm OR 95% CI p-value
n (Implants) 42 26
Suppuration
No 17 (40.5) 4 (15.4) 1
Yes 25 (59.5) 22 (84.6) 5.02 1.22–20.6 .025*
BOP
No 0 (0.0) 0 (0.0)
Yes 42 (100) 26(100) — — 1.000
% MBL .014*
<25% 30 (73.3) 5 (19.2) 1
25%–50% 9 (21.5) 13 (50.0) 5.43 1.45–20.4 .012*
>50% 3 (7.2) 8 (30.8) 10.9 1.75–67.9 .011*
Mean MBL (mm) 2.66 ± 1.24 4.38 ± 2.13 1.62 1.15–2.28 .005**
Mean PPD (mm) 5.67 ± 1.59 5.75 ± 1.34 0.88 0.62–1.24 .451
Abbreviations: BOP, bleeding on probing; MBL, marginal bone level; PPD, peri-implant probing 
depths.
*p < .05; **p < .01.
TA B L E  2   Clinical and radiographical 
parameters occurring from T0 to T1 
utilizing the width KM at T0 as the 
predictor
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sites with ≥2 mm and <2 mm KM, respectively. Overall, no significant 
influence of the KM width on the criteria was found between the 
groups (p > .05).
4  | DISCUSSION
4.1 | Principal findings
The significance of KM width on frequency of peri-implant diseases 
is a heavily debated subject in the literature. Current evidence un-
derlines the importance of frequent periodontal and peri-implant 
maintenance, suggesting that in highly compliant patients, KM plays 
a null role in the prevention of biological complications (Lim et al., 
2019). Conversely, in poorly compliant patients, the presence of 
≥2 mm of KM has been demonstrated to be beneficial for long-term 
outcomes (Monje & Blasi, 2019; Romanos, Grizas, & Nentwig, 2015). 
Generally, the influence of peri-implant KM on peri-implantitis ther-
apeutic outcomes is poorly understood.
Findings from this retrospective analysis suggest that peri-im-
plant sites with minimal KM display more severe forms of peri-im-
plantitis. Nevertheless, our results failed to exhibit an association 
between the width of the initial band of KM and the therapeu-
tic outcome of peri-implantitis. Our findings revealed that lower 
MBL around implants prior to surgical treatment contributes 
towards therapeutical success and implant survival to a greater 
extent than KM width. However, the presence of ≥2 mm of KM 
around implant sites diagnosed with peri-implantitis led to higher 
survival rates compared to sites lacking KM. Regardless of the 
presence or absence of KM, severe forms of peri-implantitis are 
more prone to showing unsatisfactory outcomes after surgical 
therapy. Following treatment, BOP was yet measured at 90% of 
sites in both groups after either therapies. Noticeable variations 
between the incidence of BOP and clinically manifested peri-im-
plantitis was previously reported (Mombelli, Muller, & Cionca, 
2012). More recently, another group reported that following 
surgical peri-implantitis therapy, no BOP was demonstrated in 
only 14% of implants treated, and almost only 2% at patient level 
KM
OR 95% CI p-value≥2 mm <2 mm
n (Implants) 29 39
Suppuration
No 13 (44.8) 8 (20.5) 1
Yes 16 (55.2) 31 (79.5) 3.15 0.99–10.0 .052
BOP
No 0 (0.0) 0 (0.0)
Yes 29 (100) 39 (100) — — 1.000
% MBL .004**
<25% 22 (75.9) 13 (33.3) 1
25%–50% 5 (17.2) 17 (43.6) 6.22 1.79–21.7 .004**
>50% 2 (6.9) 9 (23.1) 8.25 1.45–47.0 .018*
Mean MBL (mm) 2.47 ± 1.25 3.98 ± 1.95 1.87 1.23–2.85 .003**
Mean PPD (mm) 5.79 ± 1.57 5.63 ± 1.44 0.93 0.69 –1.26 .628
Abbreviations: BOP, bleeding on probing; MBL, marginal bone level; PPD, peri-implant probing 
depths.
*p < .05; **p < .01; ***p < .001. 
TA B L E  3   Clinical and radiographical 
parameters prior to surgical treatment of 
peri-implantitis (T1)
Implant failure
OR 95% CI p-valueNo Yes
n (implant) 56 12
KM
≥2 mm 28 (96.6) 1 (3.4) 1




MBL 1.65 0.99–2.72 .05
TA B L E  4   Clinical and radiographical 
parameters between T1 and T2 adjusted 
by number of maintenance visits and MBL 
utilizing KM at T1 as predictor
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(Koldsland, Wohlfahrt, & Aass, 2018). Both findings in addition 
to the results of the current study agree with the conclusions of 
a recent systematic review; that the extent to which BOP can 
identify peri-implantitis seems to be limited (Hashim, Cionca, 
Combescure, & Mombelli, 2018). Noteworthy is also that only 
one group (KM ≥ 2mm) experienced bone gain (Figure 2b). This 
might be partially explained by the wide-ranging standard devi-
ation we had, were few implants had modest amounts of bone 
gain, others had significant bone loss. In contrast, a systematic 
review reported that 10.4% of the included implants from six clin-
ical trials showed complete bone fill, 85.5% showed partial de-
fect fill and only 4% experienced bone loss (Sahrmann, Attin, & 
Schmidlin, 2011).
4.2 | Agreements and disagreements with 
previous studies
Peri-implantitis is characterized by a non-linear and accelerating pat-
tern of peri-implant marginal bone loss (Derks et al., 2016), where a 
lack of KM has been suggested to contribute towards the onset of peri-
implantitis (Gobbato et al., 2013; Lin et al., 2013). In fact, a very recent 
prospective follow-up study demonstrated that KM width and time in 
function had a statistically significant effect on MBL (Perussolo, Souza, 
Matarazzo, Oliveira, & Araujo, 2018). This was supportive of previous 
findings (Zigdon & Machtei, 2008). Schwarz et al. (2018a) showed that 
sites with ≥2 mm KM displayed less efficient resolution of experimen-
tal peri-implant mucositis. Our findings underlined that the lack of KM 
contributes towards increased peri-implantitis severity.
This study is the first to investigate the impact of KM width on 
peri-implantitis therapeutic outcomes. Recent clinical trials concurred 
that non-surgical treatments are often insufficient in preventing further 
bone loss at peri-implantitis sites, and that only surgical approaches sig-
nificantly diminish the progression of bone loss (Faggion, Listl, Fruhauf, 
Chang, & Tu, 2014; Karlsson et al., 2019). It is also safe to assume that 
surgical interventions are best reserved for moderate and advanced 
peri-implantitis cases (Aljateeli, Fu, & Wang, 2012; Esposito, Grusovin, 
& Worthington, 2012). As for the modality of surgery, a systematic 
review that investigated different surgical modalities for treatment 
of peri-implantitis was unable to support a specific type of treatment 
modality (Heitz-Mayfield & Mombelli, 2014). Our findings further elu-
cidated that advanced bone loss present at the time of peri-implantitis 
treatment has a major impact on determining therapeutic outcomes. 
Hence, the therapeutic prognosis of advanced forms of peri-implantitis 
in the vast majority of cases is unfavourable or hopeless, regardless 
of the presence or lack of KM. In this sense, 7 of the 11 failures in the 
<2 mm KM group presented at T1 with MBL > 50%. Our study demon-
strated there was no difference in PI, PPD reduction or MBL between 
both KM groups at T2. However, the effects of KM width on SUP need 
further clarification, since resective procedures decreased SUP from 
72.2% to 5.6% in the <2 mm KM group, but only decreased SUP from 
57% to 42.9% in the ≥2 mm KM group (p < .01). It is speculated that 
this marked reduction of SUP is merely due to the high implant failure 
rate seen in the <2 mm KM group, where nine implants with SUP failed, 
and thus were not included in the analysis. Based on our analysis, each 
F I G U R E  2   Changes in probing pocket depths (PPDs) (a) and 
implant marginal bone loss (MBL) (b) between T1 and T2 according 
keratinized mucosa (KM) width
KM
OR 95% CI p-value≥2 mm <2 mm
n (Implants) 29 39
Criteria 1
Success 3 (10.3) 3 (7.7) 1 .704
Failure 26 (89.7) 36 (92.3) 1.39 0.26–7.41
n (Implants) 22 17
Criteria 2 (Regeneration)
Success 2 (9.1) 4 (23.5) 1 .299
Failure 20 (90.9) 13 (76.5) 0.33 0.04–2.65
TA B L E  5   Treatment success rate at 
final recall (T2)
     |  537RAVIDÀ et Al.
additional millimetre of MBL increased the risk of implant failure by 
65%. While such association has not been reported in previous clinical 
trials, it seems to be in agreement with the general consensus of the 
literature (Froum & Rosen, 2012; Schwarz, Sahm, Schwarz, & Becker, 
2010; Sinjab, Garaicoa-Pazmino, & Wang, 2018).
All patients recruited for this study were compliant with peri-im-
plant maintenance therapy having a minimum of one maintenance 
session per year after treatment of peri-implantitis. A recent study 
investigated the outcomes of surgically treated implants with 
peri-implantitis that were maintained regularly (Serino, Turri, & Lang, 
2015). Results showed that 39% of the treated implants had con-
comitant BOP/SUP upon probing after 6 months. Interestingly, in 
our study GI scores were significantly lower at sites with <2 mm KM 
(1.56 ± 0.64) than sites with ≥2 mm KM (1.92 ± 0.57). It is notewor-
thy that our patients that fell within the <2 mm KM group exhibited 
a relatively increased frequency of supportive peri-implant mainte-
nance visits from T1 to T2. This is in agreement with previous find-
ings (Lim et al., 2019).
Treatment success was set according to the most commonly used 
criteria proposed by Heitz-Mayfield and Mombelli (Heitz-Mayfield 
& Mombelli, 2014) and a specific criteria intended for regenera-
tive approaches (Mombelli et al., 1987; Renvert, Roos-Jansaker, et 
al., 2018; Roos-Jansaker et al., 2014). Our treatment success rates 
might seem to be significantly lower compared with other studies 
(Heitz-Mayfield et al., 2018; Renvert, Roos-Jansaker, et al., 2018), 
mainly due to a high rate of residual BOP at T2. BOP has been sug-
gested to be a clinical sign of peri-implant mucositis and peri-implan-
titis. As inferred before, the magnitude to which BOP, as a single 
variant, indicates the presence of peri-implantitis remains unknown 
(Monje, Caballe-Serrano, et al., 2018a). Marked variations between 
the incidence of BOP and clinically manifested peri-implantitis exist 
(Mombelli et al., 2012). In fact, assessments comparing teeth and 
implants in the same patients have shown that in the absence of 
disease, BOP was more frequent at implant sites (Cionca, Hashim, 
Cancela, Giannopoulou, & Mombelli, 2016). These findings could re-
sult from disturbing blood vessels due to an increased depth of probe 
penetration into healthy peri-implant mucosa. Hence, careful inter-
pretation of BOP values is necessary, since it might lead to a high 
false-positive rate when identifying the presence of peri-implant 
disease. Assessment of bleeding tendency using the modified sulcus 
bleeding index, or mucosal inflammation using the implant mucosal 
index, is likely more accurate in the detection of true peri-implant 
breakdown (French, Cochran, & Ofec, 2016; Mombelli et al., 1987; 
Monje, Insua, et al., 2018b).
4.3 | Limitations and recommendations for 
future studies
Our study is not free of limitations inherent to the retrospective 
design of the investigation. Although our study included only com-
pliant patients, some could be considered erratic compliers (<2 
visits/year). Erratic compliers have been reported to perform as 
poorly as non-compliant patients (Monje, Wang, & Nart, 2017). 
Furthermore, the length, diameter, brand and surface treatment 
of implants were not included in the multivariate analysis, since 
the number of implant variations used was too substantial to yield 
statistical significance for the patient sample studied. Due to the 
multi-level design of the statistical analysis, a power of 72% was 
reached.
It should be noticed that the implant literature has been scarce 
in terms of considering KM association with the outcome of surgical 
procedures of peri-implantitis. Efforts should therefore be under-
taken to include such outcome measures in future clinical studies.
5  | CONCLUSION
Peri-implant bone loss as a result of peri-implantitis is further ag-
gravated in scenarios lacking KM. Nevertheless, surgical outcome in 
treating peri-implantitis was influenced by the severity of bone loss 
present at the time of treatment and not by the presence of kerati-
nized mucosa at the time of treatment. Hence, the assessment of 
peri-implant bone loss prior to surgical therapy is a more accurate 
predictor of therapeutic outcomes when treating peri-implantitis.
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